.navbar .collapse { display: block; } .mobile-nav { max-height: none !important; } @media screen and (min-width: 1200px) { .navbar #basic-navbar-nav .navbar-nav { position: static !important; } }

Ariela Noy, MD

Articles

Dr. Noy on Next Phase of a Trial With Devimistat in Relapsed/Refractory Burkitt Lymphoma

May 15th 2020

Ariela Noy, MD, discusses the next phase of a trial with devimistat in patients with relapsed/refractory Burkitt lymphoma.

Dr. Noy on the Rationale to Evaluate Devimistat in Burkitt Lymphoma

December 19th 2019

Ariela Noy, MD, a medical oncologist at Memorial Sloan Kettering Cancer Center, discusses the rationale to evaluate devimistat (CPI-613) in patients with either Burkitt lymphoma/leukemia or high-grade B-cell lymphoma.